146 related articles for article (PubMed ID: 35349406)
1. Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease.
Campochiaro C; Farina N; Tomelleri A; De Luca G; Cavalli G; Dagna L
Clin Exp Rheumatol; 2022 Sep; 40(8):1598-1599. PubMed ID: 35349406
[No Abstract] [Full Text] [Related]
2. [Severe hepatitis in a patient with adult-onset Still's disease treated with anakinra].
Diallo A; Mekinian A; Boukari L; Mouas H; Zamy M; Nahon P; Gérin M; Fain O
Rev Med Interne; 2013 Mar; 34(3):168-70. PubMed ID: 23182291
[TBL] [Abstract][Full Text] [Related]
3. Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.
Ruiz PJ; Masliah E; Doherty TA; Quach A; Firestein GS
Ann Rheum Dis; 2007 Mar; 66(3):422-3. PubMed ID: 17179171
[No Abstract] [Full Text] [Related]
4. Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra.
Choi AD; Moles V; Fuisz A; Weissman G
Int J Cardiol; 2014; 172(1):e225-7. PubMed ID: 24461482
[No Abstract] [Full Text] [Related]
5. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
[No Abstract] [Full Text] [Related]
6. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
Guignard S; Dien G; Dougados M
Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
[TBL] [Abstract][Full Text] [Related]
7. Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
Vordenbäumen S; Ostendorf B; Sander O; Richter J; Schneider M
Ann Rheum Dis; 2009 Mar; 68(3):450-1. PubMed ID: 19213754
[No Abstract] [Full Text] [Related]
8. Anakinra for Adult-Onset Still's Disease Despite Old Age.
Marketos N; Patelli A; Papadopoulou-Marketou N; Ioakeimidis D
J Clin Rheumatol; 2021 Dec; 27(8S):S732-S734. PubMed ID: 32804753
[No Abstract] [Full Text] [Related]
9. [Anakinra in refractory adult onset Still's disease].
Vercoutere W; Starmans-Kool M; Peeters RM
Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset Still's disease with prominent polyserositis.
Farooq Sheikh AS; Marks J; Hopkinson N
Scott Med J; 2018 May; 63(2):63-66. PubMed ID: 29506437
[TBL] [Abstract][Full Text] [Related]
11. Subacute liver failure following anakinra treatment for adult-onset Still disease.
Aly L; Iking-Konert C; Quaas A; Benten D
J Rheumatol; 2013 Oct; 40(10):1775-7. PubMed ID: 24085761
[No Abstract] [Full Text] [Related]
12. Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.
Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S
Mod Rheumatol; 2014 Nov; 24(6):1030-1. PubMed ID: 24313885
[No Abstract] [Full Text] [Related]
13. Efficacy of anakinra in a case of refractory Still disease.
Debiais S; Maillot F; Luca L; Buret J; Fautrel B; Renard JP
J Clin Rheumatol; 2008 Dec; 14(6):357-8. PubMed ID: 19033875
[No Abstract] [Full Text] [Related]
14. Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra).
Fischer-Betz R; Specker C; Schneider M
Clin Exp Rheumatol; 2011; 29(6):1021-3. PubMed ID: 22153586
[TBL] [Abstract][Full Text] [Related]
15. [Refractory adult-onset Still's disease].
Fain O; Rouaghe S; Stirnemann J
Rev Prat; 2010 Mar; 60(3):314. PubMed ID: 20402117
[No Abstract] [Full Text] [Related]
16. Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.
Vercruysse F; Barnetche T; Lazaro E; Shipley E; Lifermann F; Balageas A; Delbrel X; Fautrel B; Richez C; Schaeverbeke T; Truchetet ME
Arthritis Res Ther; 2019 Feb; 21(1):53. PubMed ID: 30755262
[TBL] [Abstract][Full Text] [Related]
17. Adult-onset Still's disease: an uncommon differential diagnosis of urticaria and treatment with anakinra.
Gesierich A; Stoevesandt J; Kneitz C; Bröcker EB; Schön MP
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):104-6. PubMed ID: 18429988
[No Abstract] [Full Text] [Related]
18. Anakinra in children and adults with Still's disease.
Vastert SJ; Jamilloux Y; Quartier P; Ohlman S; Osterling Koskinen L; Kullenberg T; Franck-Larsson K; Fautrel B; de Benedetti F
Rheumatology (Oxford); 2019 Nov; 58(Suppl 6):vi9-vi22. PubMed ID: 31769856
[TBL] [Abstract][Full Text] [Related]
19. Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: drug reintroduction can be successful.
Perrin F; Néel A; Graveleau J; Ruellan AL; Masseau A; Hamidou M
Presse Med; 2014 Mar; 43(3):319-21. PubMed ID: 24456697
[No Abstract] [Full Text] [Related]
20. Cutaneous delayed hypersensitivity from anakinra - The importance of clinical suspicion and skin testing.
Alen Coutinho I; Saraiva AP; Cunha F; Luís M; Todo Bom A
Contact Dermatitis; 2021 Sep; 85(3):381-382. PubMed ID: 33861883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
